2
Participants
Start Date
January 27, 2022
Primary Completion Date
November 1, 2022
Study Completion Date
November 1, 2022
Lumasiran
Lumasiran will be administered by SC injection.
Placebo
Placebo will be administered by SC injection.
Clinical Trial Site, Garden City
Clinical Trial Site, Albany
Clinical Trial Site, Greensboro
Clinical Trial Site, North Charleston
Clinical Trial Site, Acworth
Clinical Trial Site, Hialeah
Clinical Trial Site, Birmingham
Clinical Trial Site, Carmel
Clinical Trial Site, Edina
Clinical Trial Site, Rochester
Clinical Trial Site, Quincy
Clinical Trial Site, Houston
Clinical Trial Site, El Paso
Clinical Trial Site, Las Vegas
Clinical Trial Site, Northridge
Clinical Trial Site, San Francisco
Clinical Trial Site, Boston
Clinical Trial Site, Brussels
Clinical Trial Site, Ghent
Clinical Trial Site, Kortrijk
Clinical Trial Site, Liège
Clinical Trial Site, Bologna
Clinical Trial Site, Pavia
Clinical Trial Site, Rome
Clinical Trial Site, Verona
Clinical Trial Site, Madrid
Clinical Trial Site, Bern
Clinical Trial Site, Lausanne
Clinical Trial Site, Zurich
Clinical Trial Site, Doncaster
Clinical Trial Site, Leeds
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY